EUVIMEDEUVIMED entdecken
Crossref

Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound

Yofinta I Salsabila, Nadia Azhaar, Muhammad Fatoni, Awik P.D. Nurhayati, Shabrina Syifa Ghaissani, Vinda Aprilia Nurul Andifa, Mardi Santoso, Fahimah Martak

International Journal of Cell and Biomedical Science · 2022

DOI: 10.59278/cbs.v1i2.20 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cell and Biomedical Science, 2022. Verfasst von Yofinta I Salsabila und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer stem cells (CSCs) are the subpopulation of cancer cells that have been demonstrated as the cause of tumor formation. The most common cancer for women and the second leading cause of death in breast cancer. Numerous genes have been involved in breast cancers, including p53. In cancer cells, p53 as well-known as the tumor suppressor gene plays an important role in directing cells with DNA damage into apoptosis. Trisindolines are heterocyclic nitrogen compounds consisting of an isatin core bearing two indole moieties that provide cytotoxic effects on cancer cells. Recently research had led to the development of the new modification of trisindoline compound into trisindoline 5.

Objective

This study aims to investigate the effect of trisindoline 5 compounds against p53 gene expression in CSCs MDA-MB-231 in vitro.

Methods

CSCs MDA-MB-231 were divided into control and treatment groups which were further analyzed in gene expression using the qPCR Livak method.

Results

Based on gene expression analysis, trisindoline 5 increases the expression of p53 in CSCs MDA-MB-231.

Conclusion

This study informed that trisindoline 5 could upregulate the expression of tumor suppressor gene p53 in CSCs MDA-MB-231 in vitro.

Zitieren

APA

Salsabila, Y. I., Azhaar, N., Fatoni, M., Nurhayati, A. P., Ghaissani, S. S., Andifa, V. A. N., Santoso, M., & Martak, F. (2022). Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound. International Journal of Cell and Biomedical Science. https://doi.org/10.59278/cbs.v1i2.20

Vancouver

Salsabila YI, Azhaar N, Fatoni M, Nurhayati AP, Ghaissani SS, Andifa VAN, et al. Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound. International Journal of Cell and Biomedical Science. 2022. doi:10.59278/cbs.v1i2.20

BibTeX
@article{Salsabila2022,
  author = {Salsabila, Yofinta I and Azhaar, Nadia and Fatoni, Muhammad and Nurhayati, Awik P.D. and Ghaissani, Shabrina Syifa and Andifa, Vinda Aprilia Nurul and Santoso, Mardi and Martak, Fahimah},
  title = {Upregulation of P53 Gene Expression on Breast Cancer Stem Cells Treated with Trisindoline 5 Compound},
  journal = {International Journal of Cell and Biomedical Science},
  year = {2022},
  doi = {10.59278/cbs.v1i2.20}
}
Kostenlos starten →